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Abstract 
A vast majority of human diseases or disorders are invariably associated with the complex regulations and 
functions of genes. These also involved in the integration of environmental signals for cells to modulate the 
functional output of the genome. The ageing process reflects the overall presentation of an organism and the 
interaction of its genes with the environment. Ageing results from a plethora of processes, which potentially 
include factors such as diabetes, immune system decline, oxidative damage, rates of apoptosis, and telomere 
shortening. Persons detected with shorter telomere lengths usually present with accelerated biological ageing, 
especially those with diabetes mellitus, glucose intolerance, and hypertension. Adverse social factors may be 
contributory to a worse prognosis for subjects with diabetes mellitus as regards early ageing.The deduction is 
that diabetes is inextricably linked with "premature ageing". There is appreciable variation in the rate of 
progression of ageing in humans. A simple biological model may not be sufficient to observe both the clinical 
and theoretical modalities to understand the mechanisms of gene-environment interaction for diabetes mellitus 
and premature ageing. The potential clinical and gerontological implications of this study are to configure the  
population at risk for developing premature ageing among diabetic patients in order to develop early therapeutic 
strategies and curtail financial costs to prevent untoward sequelae. 
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1. INTRODUCTION 
The accelerated ageing disorders or diseases such as type 2 diabetes, cancer, atherosclerosis and cardiovascular 
are essentially genetic perturbations which exacerbate exponentially with increased lifespan. Ageing or 
senescence increases susceptibility to age-related diseases, whereas genetics is a determinant of susceptibility or 
resistance in intra- or inter-species relationship.The world wide prevalence of diabetes has now reached epidemic 
dimensions; with the prevalence of type 2 diabetes (T2D) becoming twice greater in the last three decades as it 
increases in a geometric rate. In 2010, the estimate of presenting diabetes was 6.4% of the global adult 
population, that is, 285 million [1,2]. Currently, the T2D incidence has been on a steady increase in the younger 
population. Diabetes is now very well associated with ageing. The associated health and financial burdens, 
challenges and constraints are expansive. The common forms of T2D present multifactorial aetiologies with 
involvement of intricate interactions of genetic, epigenetic and environmental attributes. The preponderant role 
of the environment, especially diet and sedentary lifestyles, in the risk of diabetes is the importance of 
accelerating prevalence of early onset T2D or prediabetic features or perturbations in young people, particularly 
children. Presently, the role of early life environment in programming or priming diabetes risk has been 
elucidated in several human and animal studies. In perspective, there has been a linkage between low 
birthweight, a proxy for suboptimal in utero growth, and diabetes risk in the adult. Diverse expositions, such as 
maternal obesity, and/or maternal diabetes may significantly impact on the health and outcomes of the offspring. 
It is pertinent for the underlying processes to be configured in order to prevent, retard or reverse a primed or 
programmed risk for T2D influenced by pre- and/or postnatal environmental attributes as to have improved 
health outcomes and ameliorate premature metabolic perturbation that would culminate in premature senescence 
[2].  
 
A vast majority of human diseases or disorders are invariably associated with the complex regulations and 
functions of genes. These also involved in the integration of environmental signals for cells to modulate the 
functional output of the genome. T2D is due to the interaction of a genetic predisposition, behavioural and 
environmental factors. T2D represented a “thrifty genotype” [3] that had a selective advantage in primitive 
periods. Persons who were “metabolically thrifty” and capable to harness and store an enhanced concentration of 
energy as fat in times of food abundance were more likely to survive famine. A vast majority of the global 
population rely on an incessant supply of calorie-dense processed foods combined with decreased physical 
activity resulting in elevated proportions of T2D prevalence. The main environmental risk factors for T2D are 
general obesity, body fat distribution [estimated by waist-to-hip circumference ratio, WHR, and intrauterine 
environment [3]. 
 
T2D is associated with the chronic increase of blood glucose concentrations combined with cellular resistance to 
the insulin hormone. How could such perturbations in glucose/insulin metabolism culminate in chronic disorders 
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related with ageing? In ageing, as in diabetes mellitus, the increase in the levels of glucose and other reducing 
sugars secondary to age-induced insulin resistance can react non-enzymatically with proteins and nucleic acids 
to develop into substances which degenerate tissue elasticity. Also, disturbances in glucose/insulin metabolism 
are related with enhanced lipid peroxidation secondary to expansive free radical formation [4]. Fat tissue secretes 
multiple metabolic active factors, which are potentially responsible for insulin resistance to be developed. 
Therefore, manipulation of diet that effect the glucose/insulin system may elongate lifespan favourably and 
decrease the incidence of chronic diseases associated with ageing. 
 
Albeit, the peak age at onset of T1D is at puberty, T1D invariably emanates in adulthood with no significant 
gender disparities in incidence among persons diagnosed before the age of 15 years [5]. The recent temporal 
increase in T1D incidence depicts an alteration in the global environment than variation in the gene population 
that goes through a litany of generations. Research has focused more on viruses and infant nutrition as the 
environmental rick factors for T1D.  
 
This paper focuses on findings of diverse terms of application to explicate further the mechanisms of gene-
environment interactions in diabetes, probably as a model in premature senescence. 
 
2. THE PARAMETERS OF AGEING AS RELATED TO DISEASES  
Ageing reflects the overall presentation of the genotype of an organism and the interaction of these genes with 
the internal and external milieu. Ageing portends a risk of evolving age-related perturbations such as diabetes 
mellitus, cardiovascular disease, cancer, dementia, and other degenerative disorders, which eventually culminate 
in death. Type 2 diabetes is believed to be inextricably linked with both an environmental component and 
genetic aetiologies. A simple biological model of ageing is well-nigh impossible due to the expansive 
complexity of organisms. However, such a model may be useful as a trajectory to observe both the clinical and 
theoretical modalities as links to understand the mechanisms of gene-environment interaction for diabetes 
mellitus and early senescence. 
 
Ageing is characterised as biological and chronological age. Chronological age is a fixed dimension based on the 
calendar, whereas biological age depicts inter-individual variation in growth and ageing [6]. Biological 
gerontology emphasises the dimension of average ageing, whereas less focus has been on the individual 
differences on the rates of ageing. The aim of ageing research is the prevention or postponement of the 
debilitative physical alterations in old age. In normal ageing, there is usual ageing in which the extrinsic factors 
highlight the effects of ageing alone; and successful ageing with extrinsic factors playing a neutral or positive 
role. In unsuccessful ageing, age-related diseases proceed faster or commence earlier than in successful ageing. 
The clinical manifestations of these diseases are more aggravated and expressed at a younger (chronological) 
age, resulting in premature morbidity and mortality [6]. Unsuccessful ageing is thus regarded as a process of 
early onset ageing or accelerated ageing, and could be limited to one organ system, progress in isolation in some 
organ systems, or have a uniform process in the entire body.  
 
The major heterogeneity within age groups has been either neglected or associated with variations in genetic 
attributes. This perspective fails to take into cognizance the crucial aspect of intrinsic factors and how 
psychosocial and physiologic variables interact, as well as the heterogeneity within different age groups. 
Individuals ageing successfully would exhibit little or no age deterioration in physiologic function, while those 
ageing "usually" would present with disease-related derangements, described as the effects of ageing. The 
distinctive strong association between diabetes and unsuccessful ageing is remarkable, probably reflecting the 
higher prevalence of diverse complications among diabetic individuals. 
 
3. MAJOR FACTORS IN THE GENE-ENVIRONMENT ASPECTS OF PREMATURE AGEING 
Longevity scientists use the tools of genomics for the generation of a molecular fingerprint of ageing and the 
development of interventions which retard or reverse the ageing process. The genotype of an individual will 
affect the rate at which an individual ages. Gerontogenes regulate the rates of ageing in certain organisms, but 
not in humans [6]. There are numerous natural and synthetic genotoxins, plants and fungi which contribute as 
sources for DNA or chromosome derangement. Since these toxins are perturbative to genetic material, they may 
effect on ageing. It is established that cellular ageing contributes to organismal ageing, but the extent to which 
organismal ageing is caused by cellular ageing remains to be established. Age-related diseases are frequently 
viewed as distinct pathologies instead of as an inevitable aspect of "normal" ageing.  
 
Studies of premature ageing have identified a defect or a mutant allele of the WRN gene responsible for where 
persons at a young (chronological age) develop certain features associated with ageing. Signs of defective DNA 
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metabolism have been identified in cells obtained from WS patients with defective WRN gene identifiable with 
the deposition of deranged DNA in cells resulting in premature development of age-related disorders [7].  
 
From cultured human fibroblasts,  to elucidate the biology of ageing and the origins of age-dependent diseases 
indicated that the replicative lifespan of cultures was inversely proportional to the chronological age of the tissue 
donor, and cultures obtained from persons with two inherited disorders of premature ageing, progeria, and 
Werner’s syndrome (WS], presented with more debilitative growth capacity. The aetiology of the accelerated 
ageing is not clear, however, genomic instability that is a strong characteristic of WS may be implicated. A 
correlation between accelerated senescence and WS ageing in vivo depicts that these kinase inhibitors could be 
the basis of antiageing therapies for patients with WS [8]. 
 
It is suggested that the several longevity- and disease-related genes in humans exert their impact by genetic 
control over cell division (9]. A vast majority of cells have a finite life span, that is, following a specific number 
of divisions, a state is reached with the possibility of no more division. The synthetic ability of DNA is impeded, 
with failure to function appropriately. This "replicative senescence" may explain certain aspects of the ageing 
process. Analysis of replicative senescence reveals that cell division is accompanied by the reduction of telomere 
lengths. Due to the long lifespan of humans and the representative short telomeres, attrition in telomere length 
may be the main determinant of human ageing both at the cellular and organ levels as well as perhaps the 
systemic level in diabetic subjects. Telomere replication is both cell cycle- and developmentally regulated, with a 
probable complex control mechanism. The pace of this biological clock fluctuates, while telomere attrition is 
vastly dependent on oxidative stress/antioxidant defence [9]. Increased glucose levels, typical of diabetic 
hyperglycaemia, induces oxidative DNA degradation, augmented telomere attrition and human vascular 
endothelial cell senescence in vitro. After the advent of chronic oxidative stress, these cells are also vulnerable to 
aberrant elongation of telomeres resulting in heterogeneity in inter-chromosome telomere DNA length. High 
glucose-induced DNA degradation leads to human endothelial cell telomere heterogeneity and results in cellular 
replicative senescence by harnessing DNA repair factors and telomere checkpoint proteins. It is pertinent to 
definitely establish that genes in animal models mimic or are an exact replica of those found in mammals.  
 
The progression of cellular senescence and ageing has been inextricably linked with degradation of nuclear and 
mitochondrial DNA (mtDNA). mtDNA is vulnerable to oxidative degradation and is included in the 
"mitochondrial theory of ageing". mtDNA may be a target for glucose-induced oxidative damage in cultured 
human endothelial cells; and increased extracellular glucose concentrations promote the generation of reactive 
oxygen species within mitochondria via augmented metabolism [10].  
 
Increased oxidative stress has a major role in the pathogenesis of diabetic complications, and it is a secondary 
indicator of end-stage tissue degradation in diabetes mellitus. Increased glycoxidation and lipoxidation products 
in plasma and tissue proteins indicate that oxidative stress is augmented in diabetes. Elevated concentrations of 
oxidizable substrates could also explain the elevation of glycoxidation and lipoxidation products in tissue 
proteins in the absence of necessarily triggering a rise in oxidative stress. The augmented chemical modification 
of proteins by carbohydrates and lipids in diabetes mellitus is a resultant effect of overload of metabolic 
pathways associated with detoxification of reactive carbonyl species, culminating in an overall increase in 
steady-state levels of reactive carbonyls generated by both oxidative and nonoxidative reactions [11].  
 
The molecular mechanisms involved in the premature senescence process associated with hyperglycaemia 
include oxidative stress, telomere shortening, decreased DNA repair capacity, and protein glycation resulting in 
the formation of advanced glycosylation endproducts (AGEs) [12]. AGEs apparently toughen or stiffen tissues, 
and are involved in several age-related conditions. Cross-linking is a special focus of research also on diabetes, a 
disorder in which complications mimic physiologic alterations that can accompany advancing age. The reaction 
between blood glucose and protein is reversible resulting in a non-toxic glycated protein. With the accumulation 
of glycated proteins a non-reversible rearrangement or Maillard reaction occurs that presents little or no toxicity 
but do form interlinked cross bridges and with other substances to form non-reactive and potentially toxic AGEs. 
With increased blood glucose levels, there is an increase in the production of AGEs. The increase of blood 
glucose levels is at a rate of 1-2% per decade with ageing. Immune cells called macrophages are able to hinder 
glycation; but this process is incomplete and the cross-link proteins (AGEs) accumulate with age. 
 
4. SEX AND AGE DISPARITIES ASSOCIATED WITH TELOMERE LENGTH  
An investigation of human telomere length disparities on single chromosome arms of persons in disparate age 
groups and sexes showed that during ageing, telomeres gradually decrease in length, with eventual culmination 
in cellular senescence. Male subjects presented with shorter telomere and higher attrition rates. Each 
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chromosome arm had its age-specific telomere length and attrition pattern, culminating in heterogeneity in 
chromosome-specific regression lines. This disparate erosion pattern may be predetermined due to the 
correlation between average telomere length of single chromosome arms in newborns and their annual attrition 
rate. In addition to sex-specific disparities, chromosome arm-specific telomere lengths were overtly identical in 
both men and women with the implication that chromosome arm specifically regulates telomere length 
independent of gender, resulting in interchromosomal telomere variations [13].  
 
The longetivity gender gap is extremely complicated and may develop from sex-related hormonal disparities and 
from somatic cell selection that are susceptible to cells more resistant to exposures over time.  Animal and 
human research showed higher telomerase activity [14] and longer telomeres in female subjects compared to 
male subjects, with estrogens contributing to the gender disparities. The cardioprotective effects of estrogens 
through indirect mechanisms on lipoprotein metabolism and by direct effects on vascular endothelial cells and 
smooth muscle cells could contribute to the decreased incidence of cardiovascular disease detected in 
premenopausal women and not in men [15]. Also, estrogens could contribute to longer telomeres in women 
compared with age-matched men, thus correlating with decreased incidence of cardiovascular disorders in 
premenopausal women [16]. 
 
In twin pairs involving both sexes of different age groups, TRF length in WBCs correlated with diastolic blood 
pressure but not with systolic blood pressure, indicating a negative association between TRF length and pulse 
pressure. The correlation between telomere length and pulse pressure was independent of gender with high 
apparent heritability as regards both parameters. Investigation of WBC telomere length and pulse pressure 
parameters which are associated with large artery stiffness – pulse pressure and pulse wave velocity [15] on 
subjects of different age groups and sexes not on antihypertensive drugs, showed negative correlation of 
telomere length with age in both sexes, and multivariate analysis showed that telomere shortening was 
significantly associated with elevated pulse pressure and pulse wave velocity only in men. Both studies revealed 
age-adjusted longer telomeres in women, implying that biological ageing is more advanced in male persons than 
in female persons [17]. Also, estrogens could contribute to longer telomeres in women compared with age-
matched men, thus correlating with decreased incidence of cardiovascular disorders in premenopausal women.  
 
The issue is whether telomere length, as a possible biomarker of biological ageing provides a more reliable 
feature than chronological age for variation in arterial stiffness, assessed by the measurement of pulse pressure 
and aortic pulse wave velocity [17]. Telomere length makes provision of an increased possibility to 
chronological age of variations in pulse pressure and pulse wave velocity among men, such that men presenting 
with shorter telomere length have greater possibility of having high pulse pressure and pulse wave velocity, 
which are indicative of large artery stiffness; whereas women had longer telomere lengths suggesting that for a 
given chronological age, the biological ageing of men is higher than that of women. Symptoms are not evident 
until endothelial/vascular dysfunction is realised, therefore, a simple and sensitive early diagnostic method such 
as pulse wave velocity requires to be developed for prevention and medical treatment in diabetic patients. A high 
concordance of TRF length observed between mothers and offsprings as well as between fathers and daughters 
(but not between fathers and sons and between spouses) is X-linked mechanism of inheritance [18].  
 
5. ENVIRONMENTAL FACTORS IN EARLY DEVELOPMENT 
It is perspicuous that there are mechanisms related to foetal programming in a multi-dimensional setting, with 
the comparison of early life growth and longevity patterns within generations. Low rates of growth in early life 
are associated with an elevation of age-related disease in later life. Early development of living organisms leads 
to a remarkable high initial damage load (HIDL), that is comparable with the extent of subsequent ageing-related 
degradation accumulating in the rest of adult life [19]. This HIDL hypothesis was tested and established in 
humans that familial transmission of lifespan from parents to their children takes a non-linear accelerating 
trajectory, with steeper slopes for the lifespan of offspring of longer lived parents. Thus, increasing evidence is 
extant to support the foetal origins of adult degenerative disorders, and early-life programming of ageing and 
longevity. The HIDL hypothesis predicts that even small progress to optimise the early developmental processes 
can potentially culminate in a formidable prevention of numerous diseases in later life to postpone age-related 
morbidity and mortality, as well as significant prolongation of healthy lifespan. 
 
Undernutrition and decreased growth in utero as well as during infancy result in more accelerated ageing in some 
systems. Several age-related diseases are associated with inadequate growth and under-nourishment in early 
life, and there may be an interaction of genetic factors with growth and nutritional influences to determine 
musculo-skeletal ageing in later life (20). It is perspicuous that under-nutrition and poor growth in foetal or early 
life may shorten longevity, while a post-weaning caloric restriction actually prolongs life. Caloric restriction 
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(CR) is a dietary regime, low in calories without undernutrition. CR has been found to extend the lifespan of 
several organisms [21]. Even though, it was suggested that CR works by decreasing the concentrations of 
reactive oxygen species during respiration, the lifespan mechanism remains polemic.  
 
Moreover, foetal programming and decreased foetal growth may be significant for the risk to develop insulin 
resistance and T2D with the implication that the ageing process may be influenced to programming in early life. 
It is not yet clear, however, if retardation of foetal or early life growth is influenced more by genetic or 
environmental factors in the pregnant woman. T2D is associated with low birthweight accompanied by obesity 
in adulthood. Individuals with the disorder may present with a peculiar pattern of growth from birth through 
childhood. It is suggested that T2D is programmed in utero with concomitant low rates of foetal growth [22].  
 
The early-life period is a critical stage of development, and influences within this period may challenge the 
metabolic status of the adult. The role of maternal and in utero impacts on the developmental precipitating of 
T2D risk in both human epidemiological studies and experimental animal models to demonstrate that early 
dietary experience are liable to exacerbate the onset of age-related metabolic perturbations and insulin resistance 
as well as T2D, obesity, hypertension and cardiovascular derangements. It is suggested that impaired maternal 
nutrition precipitates a prediabetes phenotype, as frequently exhibited as insulin resistance in early stages of life. 
Therefore, maternal diet constitutes a critical determinant of premature T2D risk. Although, the processes which 
link early nutrition with age-related metabolic decrease are not clear, it may be that dysfunctions in a number of 
mechanisms are inextricably linked in cellular aging, such as alterations in longevity-associated Sirtuin activity, 
epigenetic regulation of specific metabolic genes, and mitochondrial perturbation. Pharmacological interactions 
in utero and dietary supplements during early postnatal life may mitigate insulin resistance and decrease T2D 
risk. Further studies may demonstrate the relationship between the early environment and prolonged impacts on 
metabolism. These will strategically augment the interventions which will prevent or ameliorate metabolic 
decline and the premature onset ofT2D in present and future generations [1] 
 
6. MODALITIES TO CURTAIL COSTS AND PREVENT THE PREMATURE SENESCENCE 
ASSOCIATED WITH DIABETES  
Aging or senescence constitutes the major risk factor for several chronic diseases, disabilities and decrease in 
health status [23, 24].  Comorbidity, complications and geriatric perturbations influence diabetes care including 
financial constraints in medical and healthcare modalities for the treatment of older adults with diabetes. 
Expansive public health programmes do help; but effective and efficient interventions, surveillance, research, 
better and improved policies need to be put in place for the accelerating diabetes burden among older adults [25]. 
Senescent cells have been identified as potential therapeutic targets to treat ageing and age-related disorders [23]. 
There are demonstrated human and animal experiments to slow or prevent premature ageing associated with 
diabetes. Given that vascular disease is accepted as an indicator of pathological ageing superimposed on normal 
vascular ageing, it could be stipulated that with current belief that the control of hyperglycaemia can successfully 
prevent microvascular, but not macrovascular perturbations. The combined efforts in the treatment of the 
entire CV risk factors [26] at the same time, for instance, hypertension and hyperglycaemia may be a success in 
obviating macrovascular disease and its manifestations instead of the sole treatment of a single risk factor.  
 
A study [27] demonstrated that a decreased number of circulating endothelial progenitor cells (EPCs) are 
involved in cardiovascular diabetes complication. In diabetic mice, the absence of adiponectin exacerbated the 
hyperglycaemia-induced reduction in circulating EPCs, and also mitigated the stimulatory influences on the 
production of EPCs, and re-endotheliazation. Treatment with adiponectin prevented elevated glucose-induced 
premature senescence. At the molecular level, adiponectin reduced elevated glucose-induced aggregation of 
intracellular reactive oxygen species and eventually suppressed activation and expression of the senescent 
marker [27]. The protective influences of adiponectin on vascular complications of diabetes are suggested to be 
partly in its capability to counteract hyperglycaemia-mediated reduction in the number of circulating EPCs. 
 
It was found that elevated glucose-induced oxidative stress exacerbated premature stress-induced senescence in 
young rat AF cells in a dose- and time-dependent feature other than replicative senescence [28]. It is suggested 
that prevention of augmented oxidative stress using strict blood glucose control is vital to ameliorate, retard or 
prevent premature intervertebral disc degeneration in young patients presenting with diabetes.  
 
Another study [29] showed that age-related reduction of beta-cell mass is marginal following maturation, and the 
decrease of beta-cell mass may be a specific process in diabetes. The effect of BMI on the islet cell structure is 
restricted in Japanese pressenting normal glucose tolerance. Islet density was elevated in the young, but 
decreased after maturation. 
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It is understandable that most medical and health personnel agree that ageing is an independent risk factor for 
human atherosclerosis, while atherosclerosis is accepted as a feature of aging in humans by numerous 
gerontologists. Increased calorie intake predisposes to diabetes and hyperinsulinaemia; in contrast, dysregulation 
of the insulin pathway has been demonstrated to induce cellular senescence in vitro [30]. Caloric restriction or 
decreased insulin signals promote the lifespan of various species and reduces biomarkers of cellular senescence 
in vivo. It is evident that cellular senescence contributes to the pathogenesis of human atherosclerosis. Senescent 
vascular cells are accumulated in human atheroma tissues and reveal diverse characteristics of derangements 
[30].  
 
Also, the senescent cardiac phenotype is associated with alterations in mitochondrial function and biogenesis 
resulting in perturbations in the provision of energy. The association between myocardial senescence and Pim 
kinases is pertinent as Pim 1-kinase is partly cardioprotective in the maintenance of mitochondrial integrity [31]. 
Thus, myocardial senescence may be enhanced by dissipation of Pim resulting in premature ageing and aberrant 
mitochondrial function. Pim kinases prevent cardiac senescence and preserve healthy mitochondria with 
resultant efficient cellular energetic attributes [31]. Furthermore, clinical data depict that metformin that is a 
hypoglycaemic agent acts as an endothelial protective substance [32]. Hyperglycaemia-induced down-regulation 
of SIRTI was significant in diabetes-induced endothelial senescence. The protective action of metformin on 
hyperglycaemia-induced endothelial dysfunction was due in part to the effects on the expression and/or activity 
of SIRTI [32]. 
 
7. DISCUSSION 
Ageing constitutes a principal biomedical challenge. Genes do regulate the process of ageing; although, the 
environment is also significant. In essence, the biomedical/biochemical processes are influenced by numerous 
genes which interact with the environment as they affect normal ageing. As the disease burden of ageing will 
invariably overwhelm the healthcare system in the coming decades, it is significant to have an expansive 
understanding of biological ageing as it relates to the presenting disease. The development of age-related 
diseases depict at varied rates in a specific individual. Subjects with diabetes mellitus seemed to age more 
prematurely than non-diabetic or healthy individuals. It is universally accepted that the rate of ageing is 
determined both genetically and environmentally. Definitely, no single factor can be indicted for the ageing 
process. Diabetes mellitus is frequently related to premature senescence syndrome [1, 2,10 ,16].  
 
Cellular ageing may potentiate the mechanisms which are associated in reducing myocardial contractility in 
diabetes and; diabetes associated with senescence may augment the risk to develop prmature ageing. The 
modulation of telomere activity and telomere length, with the mitigation of the formation of reactive oxygen 
species are crucial novel targets for developing therapeutic roles to prevent premature ageing. Increasing 
reduction in telomere length has been indicated in several diseases including T2D. These depicted that the 
shortening of  telomere length increases as diabetes progresses. The detection time of progression is suggestive 
that there exists a simultaneous corresponding acceleration of inflammation and/or oxidative stress that relates 
directly with telomere shortening [33]. Although, reduced telomere length are related to several risk factors of 
diabetes, there is emphasis on the clustering of augmented ageing characteristics, such as shortened telomeres, 
decreased mtDNa levels, hypoadiponectinemia, decreased HDL, and high oxidative stress in T2D patients [34]. 
Insulin receptor signaling has revealed that down regulation of insulin receptor signaling via CR augments the 
life span in mice [35]. 
 
Hyperglycaemia as a common denominator and hallmark of the different states of diabetes mellitus is poor 
metabolic control, and is an internal environmental promoter both of pathophysiological processes culminating 
in premature senescence and, for example, of gene up-regulation resulting in vascular damage. This process of 
premature senescence associated with hyperglycaemia is measurable/detectable in numerous organs and are 
potentially preventable. A support of the latter statement is that a healthy lifestyle has been found to stem the 
transition from IGT to overt T2D [36], and, therefore, the risk of organ damage from hyperglycaemia. It has 
been established that the Amadori product, glycated albumin, augments premature cell senescence in mesangial 
cells by the activation of the insulin growth factor, IGF-1 receptor signaling pathways and the resultant decrease 
in the antioxidant enzyme catalase [37]. Amadori products are present in debilitative conditions such as, diabetes 
and ageing; and are invariably associated in diabetic nephropathy or age-related renal dysfunction. 
 
A strong defence against free radicals is the manufacture by the body of antioxidants, which are able to 
neutralise the oxygen radicals [38], and eliminate the deranging effects. However, animal studies have not yet 
directly established that the use of natural antioxidants, such as vitamin E lead to the improvement of health or 
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extend lifespan. Scientists are searching for other avenues to combat oxidative stress, because free radicals 
constitute just a class of toxins encountered daily. The scientific data undergirding the usage of antioxidants as 
dietary supplements are mixed, with no evidence that consumption of any currently available antioxidant 
compound contributes beneficially to the rate of human ageing. It is possible to eventually develop similar 
compounds to ameliorate oxidative stress in humans and retard or decrease certain age-related disorders [39, 40]. 
A clear understanding of the up-regulation by hyperglycaemia of genes associated with ageing may provide 
more latitude to understand the process.  
 
8. CONCLUSION  
Expansive studies are required for the evaluation of various markers of glycaemia, and relevant metabolic 
abnormalities in the ageing of individuals with diabetes mellitus. It is pertinent to investigate mechanisms related 
to foetal programming in a multi-dimensional setting, with the comparison of early life growth and longevity 
patterns encompassing generations. WBCs are proliferative cells, which are readily available from 
humans. These cells have been employed to determine whether telomere dynamics can provide information in 
addition to chronological age, about vulnerability to disturbances of ageing. Inasmuch as, telomere dynamics 
may provide information with respect to the biology of ageing, a model linking telomere dynamics, diabetes 
mellitus, and gene-environment interaction is appreciable. Telomere length decreased in WBCs from T1D 
patients in comparison to age-matched nondiabetic persons. This parameter was not distinguishable when 
compared to T2D patients and nondiabetic controls, and was suggested that telomere shortening presents in 
subsets of WBCs which are involved in the pathogenesis of T1D. Does this suggest that telomere length has no 
correlation with ageing? The shortened terminal restriction fragment (TRF) length of WBCs of subjects with 
T1D possibly reflects a significant decrease in the TRF length of subsets of WBCs which are involved in the 
pathogenesis of T1D [41].  
 
To assess telomere length is important because telomeres are useful to identify most abnormal cellular 
phenotypes, determine the efficacy of inhibitors, and provide prognostic information helpful in guiding treatment 
modalities. Therefore, the methods for measuring telomere length need to be efficient and facilitate the process 
to determine minute and subtle alterations in telomere length. Obviously, telomere length is a marker of 
telomerase activity, and its measurement by various methods are of use. The quantitative flow FISH in 
combination with digital microscopy will enhance efficient large-scale sample processing and analysis of 
telomere lengths. It is required to determine the efficacy of novel therapeutic regimens directed at the 
modification of telomere length. Therefore, encompassing and basic research and epidemiological studies are 
necessary to determine if telomere attrition is an exclusive cardiometabolic risk factor or the resultant effect of 
age-associated disorders. The rapidity of telomere length shortening may be a surrogate for the chronic oxidative 
stress [42] and/or inflammation. Accelerated telomere shortening is may be associated with ethnicity [43], 
gender [44] and lifestyle disorders which are linked to some metabolic factors, for instance, obesity, insulin 
resistance, hypernutrition and sedentary lifestyle [45].  
 
It has been demonstrated how stress-induced anabolic/catabolic imbalance, expressed partly by elevated cortisol, 
glucose and insulin as well as decreased androgens and growth hormones may result in oxidative stress and 
systemic inflammation leading to impairment of cell ageing processes. High intake of energy-enriched food and 
obesity play a vital mediating role in this trajectory. These cause insulin resistance and the enhancement of 
energy storage in abdominal fat tissue. This body habitus is related to systemic inflammation and oxidative stress 
which impact on cell metabolism with resultant acceleration of cellular ageing with possible effect on autophagy, 
sirtuins and telomere maintenance [46]. Since the ageing process as related to premature cellular senescence is a 
multifactorial and extremely variable entity that causes several dysfunctional states in tissues, the application of 
telomere length gives new and ample opportunity for research into metabolic and cardiovascular anomalies, 
especially diabetes mellitus. An investigation in the relatedness between genetic polymorphisms with functional 
impacts on redox regulation in subjects with T2D, that after adjustment for age, gender, smoking, BMI, diabetes 
duration and lipid parameters, the carriers of GSTM1/GSST1-null haplotype depicted an augmented risk for 
myocardial infarction [47]. It is suggested that GSTM1/GSTT1 haplotype is a genetic risk factor for myocardial 
infarction in patients with T2D. 
 
The increased rate of changes in glucose regulation in adults may be due to a complex set of risk factors which 
contribute to augmentation of insulin resistance with ageing and deranged pancreatic islet cell function [48]. The 
age-associated insulin resistance is principally due to lifestyle factors; and, therefore, improvement in diet and 
exercise may be useful in preventing progression to diabetes and premature senescence. Also, there exist age-
associated declines of pancreatic islet function and possible proliferative capacity resulting from both ageing 
effects on the islets and genetic factors [49]. Although, sustainable parameters in lifestyle may retard age-
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associated hyperglycaemia partly by decreasing demand on extant beta cells, it is possible that several other 
adults will eventually succumb to diabetes until there are viable interventions to delay or eliminate the effects of 
ageing on pancreatic islet function, as an attribute for the management of hyperglycaemia in persons with type 2 
diabetes [3, 49].  
 
Cells do regulate the ageing process, and the environment playa a vital role resulting in early onset rather than 
normal ageing in diseases such as diabetes. The ageing process as determined by gene-environment interactions 
are unaltered with age-related diseases (46) or disorders such as insulin resistance and diabetes. The ageing 
process reflects the overall presentation of an organism and the interaction of its genes with the environment. 
Ageing results from a plethora of processes, which potentially include factors such as diabetes, immune system 
decline, oxidative damage, rates of apoptosis, and telomere shortening.  The potential clinical and gerontological 
implications of this study are to configure the  population at risk for developing premature ageing among 
diabetic patients in order to develop early therapeutic strategies to prevent untoward sequelae. Diabetes mellitus 
associated to premature aging may increase the risk of developing a cardiomyopathy. Thus, the modulation of 
telomerase activity and the control of telomere length, as well as the amelioration of the formation of reactive 
oxygen species could form valuable new targets to develop therapeutic tools to prevent diabetic complications 
resulting in premature senescence. Early life development and lifestyle also affect the ageing process. Calorie 
restriction may be of therapeutic value as used currently as a paradigm to develop substances which promote and 
extend life. There must be expansive interventions (50) to mitigate the impacts of the metabolic syndrome and 
type 2 diabetes. It is, therefore, clear that diabetes is inextricably linked with "premature ageing". There is 
appreciable variation in the rate of progression of ageing in humans. A simple biological model may not be 
sufficient to observe both the clinical and theoretical modalities to understand the mechanisms of gene-
environment interaction for diabetes mellitus and premature ageing.  
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